These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
108 related items for PubMed ID: 7564103
1. Human mesangial cell production of monocyte chemoattractant protein-1: modulation by lovastatin. Kim SY, Guijarro C, O'Donnell MP, Kasiske BL, Kim Y, Keane WF. Kidney Int; 1995 Aug; 48(2):363-71. PubMed ID: 7564103 [Abstract] [Full Text] [Related]
2. Effects of lipids on the pathogenesis of progressive renal failure: role of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in the prevention of glomerulosclerosis. Guijarro C, Keane WF. Miner Electrolyte Metab; 1996 Aug; 22(1-3):147-52. PubMed ID: 8676808 [Abstract] [Full Text] [Related]
3. Lovastatin inhibits proliferation of rat mesangial cells. O'Donnell MP, Kasiske BL, Kim Y, Atluru D, Keane WF. J Clin Invest; 1993 Jan; 91(1):83-7. PubMed ID: 8423236 [Abstract] [Full Text] [Related]
4. Lovastatin inhibits lipopolysaccharide-induced NF-kappaB activation in human mesangial cells. Guijarro C, Kim Y, Schoonover CM, Massy ZA, O'Donnell MP, Kasiske BL, Keane WF, Kashtan CE. Nephrol Dial Transplant; 1996 Jun; 11(6):990-6. PubMed ID: 8671958 [Abstract] [Full Text] [Related]
5. Lovastatin reduces glomerular macrophage influx and expression of monocyte chemoattractant protein-1 mRNA in nephrotic rats. Park YS, Guijarro C, Kim Y, Massy ZA, Kasiske BL, Keane WF, O'Donnell MP. Am J Kidney Dis; 1998 Jan; 31(1):190-4. PubMed ID: 9428473 [Abstract] [Full Text] [Related]
6. Low-density lipoprotein-induced expression of interleukin-6, a marker of human mesangial cell inflammation: effects of oxidation and modulation by lovastatin. Massy ZA, Kim Y, Guijarro C, Kasiske BL, Keane WF, O'Donnell MP. Biochem Biophys Res Commun; 2000 Jan 19; 267(2):536-40. PubMed ID: 10631097 [Abstract] [Full Text] [Related]
7. Effect of inhibition of cholesterol synthetic pathway on the activation of Ras and MAP kinase in mesangial cells. Bassa BV, Roh DD, Vaziri ND, Kirschenbaum MA, Kamanna VS. Biochim Biophys Acta; 1999 Mar 08; 1449(2):137-49. PubMed ID: 10082972 [Abstract] [Full Text] [Related]
9. Bone morphogenetic protein-7 inhibits constitutive and interleukin-1 beta-induced monocyte chemoattractant protein-1 expression in human mesangial cells: role for JNK/AP-1 pathway. Lee MJ, Yang CW, Jin DC, Chang YS, Bang BK, Kim YS. J Immunol; 2003 Mar 01; 170(5):2557-63. PubMed ID: 12594282 [Abstract] [Full Text] [Related]
10. The mevalonate pathway: importance in mesangial cell biology and glomerular disease. O'Donnell MP, Kasiske BL, Kim Y, Atluru D, Keane WF. Miner Electrolyte Metab; 1993 Mar 01; 19(3):173-9. PubMed ID: 8232104 [Abstract] [Full Text] [Related]
11. HMG-CoA reductase inhibitors decrease CD11b expression and CD11b-dependent adhesion of monocytes to endothelium and reduce increased adhesiveness of monocytes isolated from patients with hypercholesterolemia. Weber C, Erl W, Weber KS, Weber PC. J Am Coll Cardiol; 1997 Nov 01; 30(5):1212-7. PubMed ID: 9350917 [Abstract] [Full Text] [Related]